These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1336774)

  • 1. Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition.
    Kimura Y; Engelman RM; Rousou J; Flack J; Iyengar J; Das DK
    Heart Vessels; 1992; 7(4):189-95. PubMed ID: 1336774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of myocardial function by trifluoperazine, a calmodulin antagonist, after acute coronary artery occlusion and coronary revascularization.
    Otani H; Engelman RM; Rousou JA; Breyer RH; Clement R; Prasad R; Klar J; Das DK
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):267-74. PubMed ID: 2915562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necrosis after acute coronary artery occlusion and surgical reperfusion.
    Melendez FJ; Gharagozloo F; Sun SC; Benfell K; Austin RE; Shemin RJ; Cohn LH
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):613-7. PubMed ID: 3352294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postischemic deterioration of sarcoplasmic reticulum: warm versus cold blood cardioplegia.
    Liu X; Engelman RM; Wei Z; Maulik N; Rousou JA; Flack JE; Deaton DW; Das DK
    Ann Thorac Surg; 1993 Nov; 56(5):1154-9. PubMed ID: 8239814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clentiazem, diltiazem, and cold cardioplegia in isolated ischemic rabbit hearts: relation between additive cardioprotection, physicochemical properties, and preservation of myocardial lipid components.
    Tanguay M; Lepage G; Blaise G; Garceau D; Dumont L
    J Cardiovasc Pharmacol; 1994 Dec; 24(6):950-9. PubMed ID: 7898079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of Ca2+ influx by manipulation of Ca2+ and/or Ca2+ antagonist in cardioplegic arrest.
    Hashimoto K; Hahimoto K [corrected to Hashimoto K]; Mashburn JP; Cartier R; Schaff HV
    Jpn Circ J; 1993 Mar; 57(3):237-44. PubMed ID: 8385232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential enhancement of postischemic segmental systolic thickening by diltiazem.
    Taylor AL; Golino P; Eckels R; Pastor P; Buja LM; Willerson JT
    J Am Coll Cardiol; 1990 Mar; 15(3):737-47. PubMed ID: 2303644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in neonatal rabbit hearts.
    Akita T; Abe T; Kato S; Kodama I; Toyama J
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):55-66. PubMed ID: 8321005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs.
    Bush LR; Romson JL; Ash JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(2):285-96. PubMed ID: 6175813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of ischemia-reperfusion-induced myocardial dysfunction by modulating calcium-overload using a novel, specific calmodulin antagonist, CGS 9343B.
    Das DK; Engelman RM; Prasad MR; Rousou JA; Breyer RH; Jones R; Young H; Cordis GA
    Biochem Pharmacol; 1989 Feb; 38(3):465-71. PubMed ID: 2917008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sevoflurane preconditioning before moderate hypothermic ischemia protects against cytosolic [Ca(2+)] loading and myocardial damage in part via mitochondrial K(ATP) channels.
    Chen Q; Camara AK; An J; Novalija E; Riess ML; Stowe DF
    Anesthesiology; 2002 Oct; 97(4):912-20. PubMed ID: 12357159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose calcium antagonists reduce energy demand and cellular damage of isolated hearts during both ischemia and reperfusion.
    Becker BF; Möbert J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):287-94. PubMed ID: 10543430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of the failing dystrophic hamster heart to the cardioprotective effects of diltiazem and clentiazem: evidence of coronary vascular dysfunctions.
    Tanguay M; Jasmin G; Blaise G; Dumont L
    Can J Physiol Pharmacol; 1995 Aug; 73(8):1108-17. PubMed ID: 8564877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular calcium increasing at the beginning of reperfusion assists the early recovery of myocardial contractility after diltiazem cardioplegia.
    Inoue K; Ando S; Itagaki T; Shiojiri Y; Kashima T; Takaba T
    Jpn J Thorac Cardiovasc Surg; 2003 Mar; 51(3):98-103. PubMed ID: 12691118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gradual onset of myocardial ischemia results in reduced myocardial infarction. Association with reduced contractile function and metabolic downregulation.
    Ito BR
    Circulation; 1995 Apr; 91(7):2058-70. PubMed ID: 7895365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diltiazem abolishes the effect of ryanodine in St. Thomas' Hospital cardioplegic solution on the post-ischemic functional recovery].
    Yamamoto H; Ichikawa H; Yamamoto F
    Nihon Kyobu Geka Gakkai Zasshi; 1995 Jan; 43(1):19-25. PubMed ID: 7884256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of diltiazem during myocardial ischemia in isolated cat hearts.
    Bush LR; Li YP; Shlafer M; Jolly SR; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Sep; 218(3):653-61. PubMed ID: 7264949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia/reperfusion injury.
    Takeo S; Tanonaka K; Iwai T; Motegi K; Hirota Y
    Biochem Pharmacol; 2004 Feb; 67(3):565-74. PubMed ID: 15037208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of "duration" of reperfusate administration versus reperfusate "dose" on regional functional, biochemical, and histochemical recovery.
    Allen BS; Okamoto F; Buckberg GD; Leaf J; Bugyi H
    J Thorac Cardiovasc Surg; 1986 Sep; 92(3 Pt 2):594-604. PubMed ID: 3747587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct size reduction with coronary venous retroinfusion of diltiazem in the acute occlusion/reperfusion porcine heart model.
    Tadokoro H; Miyazaki A; Satomura K; Rydén L; Kaul S; Kar S; Corday E; Drury K
    J Cardiovasc Pharmacol; 1996 Jul; 28(1):134-41. PubMed ID: 8797147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.